Concepedia

Sharmin Khan

SK

Statistics

Publications

14

Citations

632

H-Index

12

Active since

2008

Affiliations

University of Arkansas for Medical Sciences(Current)

Indiana University – Purdue University Indianapolis

Central Arkansas Veterans Healthcare System

Ferrarotto Hospital

University of Catania

Sharmin Khan is an author at University of Arkansas for Medical Sciences specializing in medicine, bone metabolism, and multiple myeloma.

Publications per year

2008–2024

14

Publications

14

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

Angela Pennisi, Xin Li, Wen Ling et al. · American Journal of Hematology · 2008 · 138 citations · Full text

, , +17

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

Angela Pennisi, Wen Ling, Xin Li et al. · Blood · 2009 · 96 citations · Full text

, , +16

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone

Xin Li, Wen Ling, Angela Pennisi et al. · Stem Cells · 2010 · 82 citations · Full text

, , +17

Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease

Rakesh Bam, Wen Ling, Sharmin Khan et al. · American Journal of Hematology · 2013 · 60 citations · Full text

, , +17

NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity

Sathisha Upparahalli Venkateshaiah, Sharmin Khan, Wen Ling et al. · Experimental Hematology · 2013 · 50 citations · Full text

, , +9

1–5 of 14